Lu Z, Zhang R, Wu P, Zhao D, Chen J, Pan X
Toxins (Basel). 2025; 17(1).
PMID: 39852962
PMC: 11769038.
DOI: 10.3390/toxins17010009.
Murashiki T, Mazhandu A, Zinyama-Gutsire R, Mutingwende I, Mazengera L, Duri K
Mycotoxin Res. 2024; 41(1):147-161.
PMID: 39549138
DOI: 10.1007/s12550-024-00571-0.
Galletta M, Combes A, Mondello L, Tranchida P, Pichon V
Anal Bioanal Chem. 2024; 417(2):265-273.
PMID: 39532728
DOI: 10.1007/s00216-024-05640-y.
Kinkade C, Brinker A, Buckley B, Waysack O, Fernandez I, Kautz A
J Expo Sci Environ Epidemiol. 2024; .
PMID: 39363096
DOI: 10.1038/s41370-024-00722-6.
McKeon H, Schepens M, van den Brand A, de Jong M, van Gelder M, Hesselink M
Toxins (Basel). 2024; 16(6).
PMID: 38922172
PMC: 11209130.
DOI: 10.3390/toxins16060278.
Associations between mycoestrogen exposure and sex steroid hormone concentrations in maternal serum and cord blood in the UPSIDE pregnancy cohort.
Kinkade C, Aleksunes L, Brinker A, Buckley B, Brunner J, Wang C
Int J Hyg Environ Health. 2024; 260():114405.
PMID: 38878407
PMC: 11441442.
DOI: 10.1016/j.ijheh.2024.114405.
Aflatoxin M Analysis in Urine of Mill Workers in Bangladesh: A Pilot Study.
Ali N, Habib A, Mahmud F, Tuba H, Degen G
Toxins (Basel). 2024; 16(1).
PMID: 38251261
PMC: 10819429.
DOI: 10.3390/toxins16010045.
Advancing probabilistic risk assessment by integrating human biomonitoring, new approach methods, and Bayesian modeling: A case study with the mycotoxin deoxynivalenol.
Lu E, Grimm F, Rusyn I, De Saeger S, De Boevre M, Chiu W
Environ Int. 2023; 182:108326.
PMID: 38000237
PMC: 10898272.
DOI: 10.1016/j.envint.2023.108326.
Ochratoxin A-The Current Knowledge Concerning Hepatotoxicity, Mode of Action and Possible Prevention.
Wieckowska M, Szelenberger R, Niemcewicz M, Harmata P, Poplawski T, Bijak M
Molecules. 2023; 28(18).
PMID: 37764392
PMC: 10534339.
DOI: 10.3390/molecules28186617.
Risk assessment of ochratoxin A in food.
Schrenk D, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B, Hogstrand C
EFSA J. 2023; 18(5):e06113.
PMID: 37649524
PMC: 10464718.
DOI: 10.2903/j.efsa.2020.6113.
Optimized extraction and analysis methods using liquid chromatography-tandem mass spectrometry for zearalenone and metabolites in human placental tissue.
Lazofsky A, Brinker A, Gupta R, Barrett E, Aleksunes L, Rivera-Nunez Z
Heliyon. 2023; 9(6):e16940.
PMID: 37484340
PMC: 10361036.
DOI: 10.1016/j.heliyon.2023.e16940.
Human biomonitoring of deoxynivalenol (DON) - Assessment of the exposure of young German adults from 1996 - 2021.
Schmied A, Marske L, Berger M, Kujath P, Weber T, Kolossa-Gehring M
Int J Hyg Environ Health. 2023; 252:114198.
PMID: 37311395
PMC: 10410250.
DOI: 10.1016/j.ijheh.2023.114198.
Maternal exposure to multiple mycotoxins and adverse pregnancy outcomes: a prospective cohort study in rural Bangladesh.
Kyei N, Waid J, Ali N, Cramer B, Humpf H, Gabrysch S
Arch Toxicol. 2023; 97(6):1795-1812.
PMID: 37067549
PMC: 10182942.
DOI: 10.1007/s00204-023-03491-7.
Impact of Deoxynivalenol and Zearalenone as Single and Combined Treatment on DNA, Cell Cycle and Cell Proliferation in HepG2 Cells.
Domijan A, Hercog K, Stampar M, Gajski G, Geric M, Sokolovic M
Int J Mol Sci. 2023; 24(4).
PMID: 36835492
PMC: 9958612.
DOI: 10.3390/ijms24044082.
Toxicokinetics and metabolism of deoxynivalenol in animals and humans.
Sun Y, Jiang J, Mu P, Lin R, Wen J, Deng Y
Arch Toxicol. 2022; 96(10):2639-2654.
PMID: 35900469
DOI: 10.1007/s00204-022-03337-8.
Combined Exposure to Multiple Mycotoxins: An Example of Using a Tiered Approach in a Mixture Risk Assessment.
van den Brand A, Bokkers B, Te Biesebeek J, Mengelers M
Toxins (Basel). 2022; 14(5).
PMID: 35622550
PMC: 9145316.
DOI: 10.3390/toxins14050303.
Biomarkers of Exposure to Zearalenone in In Vivo and In Vitro Studies.
Llorens P, Herrera M, Juan-Garcia A, Paya J, Molto J, Arino A
Toxins (Basel). 2022; 14(5).
PMID: 35622538
PMC: 9142966.
DOI: 10.3390/toxins14050291.
Assessment of multiple mycotoxin exposure and its association with food consumption: a human biomonitoring study in a pregnant cohort in rural Bangladesh.
Kyei N, Cramer B, Humpf H, Degen G, Ali N, Gabrysch S
Arch Toxicol. 2022; 96(7):2123-2138.
PMID: 35441239
PMC: 9151532.
DOI: 10.1007/s00204-022-03288-0.
High-Throughput Determination of Major Mycotoxins with Human Health Concerns in Urine by LC-Q TOF MS and Its Application to an Exposure Study.
Pallares N, Carballo D, Ferrer E, Rodriguez-Carrasco Y, Berrada H
Toxins (Basel). 2022; 14(1).
PMID: 35051019
PMC: 8780005.
DOI: 10.3390/toxins14010042.
Human Biomonitoring of Selected Hazardous Compounds in Portugal: Part II-Lessons Learned on Mycotoxins.
Pena A, Duarte S, Pereira A, Silva L, Laranjeiro C, Oliveira M
Molecules. 2022; 27(1).
PMID: 35011364
PMC: 8747060.
DOI: 10.3390/molecules27010130.